Jpmorgan Chase & CO Athersys, Inc Transaction History

Jpmorgan Chase & CO

  • $1.14 Trillion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022
BUY
$0.18 - $0.86 $155,065 - $740,868
861,475 Added 37.56%
3,155,103 $820,000
Q1 2022

May 11, 2022
SELL
$0.6 - $1.06 $105,450 - $186,296
-175,751 Reduced 7.12%
2,293,628 $1.39 Million
Q4 2021

Feb 10, 2022
SELL
$0.85 - $1.4 $478,874 - $788,734
-563,382 Reduced 18.58%
2,469,379 $2.23 Million
Q3 2021

Nov 12, 2021
BUY
$1.33 - $1.77 $4.03 Million - $5.37 Million
3,032,761 New
3,032,761 $4.03 Million

About ATHERSYS, INC

ATHX Quotes by TradingView
  • Ticker ATHX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 305,110,016
  • Market Cap $3.05M
  • Description
  • Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...
More about ATHX
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email